Francesco Chiancone

11PUBLICATIONS
18CO-AUTHORS
Cancer cell biologyMolecular targetsPredictive and prognostic markersEcohydrologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Feb 26, 2026
BLOSSOM Dietary Habits and 1-Year Intravesical Recurrence in High-Risk Non-Muscle-Invasive Bladder Cancer Treated with BCG.

Carlo Buonerba, Raffaele Baio, Felice Crocetto

|Feb 15, 2022
Novel Therapeutic Opportunities in Neoadjuvant Setting in Urothelial Cancers: A New Horizon Opened by Molecular Classification and Immune Checkpoint Inhibitors.

Maria Lucia Iacovino, Chiara Carmen Miceli, Marco De Felice

|Jul 19, 2021
A risk-group classification model in patients with bladder cancer under neoadjuvant cisplatin-based combination chemotherapy.

Matteo Ferro, Giuseppe Lucarelli, Ottavio de Cobelli

|Jul 14, 2021
Neutrophil percentage-to-albumin ratio predicts mortality in bladder cancer patients treated with neoadjuvant chemotherapy followed by radical cystectomy.

Matteo Ferro, Dragoş-Florin Babă, Ottavio de Cobelli

|May 12, 2021
Editorial Comment to Early return to continence and potency with use of dehydrated human umbilical cord graft at the time of robot-assisted radical prostatectomy: A case study and analysis of relevant literature.

Francesco Chiancone

|Mar 25, 2021
Impact of systemic inflammatory markers on the response to Hyperthermic IntraVEsical Chemotherapy (HIVEC) in patients with non-muscle-invasive bladder cancer after bacillus Calmette-Guérin failure.

Francesco Chiancone, Marco Fabiano, Maurizio Carrino

Pageof 2

Frequent Collaborators

2 joint publications

Marco Fabiano

2 joint publications

Felice Crocetto

1 joint publications

Alessandro Izzo

1 joint publications

Matteo Ferro